Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Apr;41(4):455-9.
doi: 10.1038/ng.342. Epub 2009 Mar 15.

A germline JAK2 SNP is associated with predisposition to the development of JAK2(V617F)-positive myeloproliferative neoplasms

Outi Kilpivaara  1 , Semanti Mukherjee, Alison M Schram, Martha Wadleigh, Ann Mullally, Benjamin L Ebert, Adam Bass, Sachie Marubayashi, Adriana Heguy, Guillermo Garcia-Manero, Hagop Kantarjian, Kenneth Offit, Richard M Stone, D Gary Gilliland, Robert J Klein, Ross L Levine
Affiliations

A germline JAK2 SNP is associated with predisposition to the development of JAK2(V617F)-positive myeloproliferative neoplasms

Outi Kilpivaara et al. Nat Genet. 2009 Apr.

Abstract

Polycythemia vera, essential thrombocythemia and primary myelofibrosis are myeloproliferative neoplasms (MPN) characterized by multilineage clonal hematopoiesis. Given that the identical somatic activating mutation in the JAK2 tyrosine kinase gene (JAK2(V617F)) is observed in most individuals with polycythemia vera, essential thrombocythemia and primary myelofibrosis, there likely are additional genetic events that contribute to the pathogenesis of these phenotypically distinct disorders. Moreover, family members of individuals with MPN are at higher risk for the development of MPN, consistent with the existence of MPN predisposition loci. We hypothesized that germline variation contributes to MPN predisposition and phenotypic pleiotropy. Genome-wide analysis identified an allele in the JAK2 locus (rs10974944) that predisposes to the development of JAK2(V617F)-positive MPN, as well as three previously unknown MPN modifier loci. We found that JAK2(V617F) is preferentially acquired in cis with the predisposition allele. These data suggest that germline variation is an important contributor to MPN phenotype and predisposition.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Principal component analysis of MPN cases and WTCCC controls. The two axes represent the first two principal components. The lower right quadrant contains the cluster of individuals believed to be of northern and western European ancestry, who were selected for further analysis.
Figure 2
Figure 2
JAK2V617F is acquired in cis with JAK2 SNP rs10974944. (a) Haplotype structure of the JAK2 locus in CEPH HapMap founders, showing that rs10974944 and exon 14 of JAK2 are in a shared haplotype approximately 3 kb apart. (b) Precise location of rs10974944 in relation to exons 12, 13 and 14, and the result of long-range PCR and clonal sequence analysis of this 3-kb fragment in a subject who was heterozygous for rs10974944 in his germline and heterozygous for JAK2V617F in affected tissue. Analysis shows that in this subject the G allele at rs10974944 is in cis with the mutant T allele at JAK2V617, whereas the C allele is in cis with the wild-type G allele at JAK2V617. The G allele was found to be in cis with the mutant T allele in 38 of 45 JAK2V617F-positive MPN cases who were heterozygous for rs10974944, suggesting that JAK2V617F is almost always acquired in cis with the risk allele at rs10974944.
Figure 3
Figure 3
Genome-wide SNP analysis of MPN cases and WTCCC controls. The arrow marks the position of rs10974944.
See this image and copyright information in PMC

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Adamson JW, Fialkow PJ, Murphy S, Prchal JF, Steinmann L. Polycythemia vera: stem-cell and probable clonal origin of the disease. N Engl J Med. 1976;295:913–916. - PubMed
    1. Gilliland DG, Blanchard KL, Levy J, Perrin S, Bunn HF. Clonality in myeloproliferative disorders: analysis by means of the polymerase chain reaction. Proc Natl Acad Sci USA. 1991;88:6848–6852. - PMC - PubMed
    1. El Kassar N, Hetet G, Li Y, Briere J, Grandchamp B. Clonal analysis of haemopoietic cells in essential thrombocythaemia. Br J Haem. 1995;90:131–137. - PubMed
    1. Tsukamoto N, et al. Clonality in chronic myeloproliferative disorders defined by X-chromosome linked probes: demonstration of heterogeneity in lineage involvement. Br J Haematol. 1994;86:253–258. - PubMed
    1. Jamieson CH, et al. The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation. Proc Natl Acad Sci USA. 2006;103:6224–6229. - PMC - PubMed

Publication types

LinkOut - more resources